| Neuroinflammation and glial cell activation in mental disorders PGC Almeida, JV Nani, JP Oses, E Brietzke, MAF Hayashi Brain, Behavior, & Immunity-Health 2, 100034, 2020 | 45 | 2020 |
| Neuropeptides and oligopeptidases in schizophrenia B Rodríguez, JV Nani, PGC Almeida, E Brietzke, RS Lee, MAF Hayashi Neuroscience & Biobehavioral Reviews 108, 679-693, 2020 | 37 | 2020 |
| Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder L Tasic, ALT Larcerda, JGM Pontes, TBBC da Costa, JV Nani, LG Martins, ... Journal of psychiatric research 119, 67-75, 2019 | 37 | 2019 |
| Impairments in peripheral blood T effector and T regulatory lymphocytes in bipolar disorder are associated with staging of illness and anti-cytomegalovirus IgG levels M Maes, JV Nani, C Noto, L Rizzo, MAF Hayashi, E Brietzke Molecular neurobiology 58, 229-242, 2021 | 33 | 2021 |
| Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders M Pedrini, B Cao, JVS Nani, RO Cerqueira, RB Mansur, L Tasic, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 93, 182-188, 2019 | 29 | 2019 |
| Effects of psychostimulants and antipsychotics on serum lipids in an animal model for schizophrenia BSB Correia, JV Nani, R Waladares Ricardo, D Stanisic, TBBC Costa, ... Biomedicines 9 (3), 235, 2021 | 24 | 2021 |
| Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia C Dal Mas, JV Nani, C Noto, CM Yonamine, GR da Cunha, RB Mansur, ... Schizophrenia Research 208, 202-208, 2019 | 15 | 2019 |
| Decreased nuclear distribution nudE-like 1 enzyme activity in an animal model with dysfunctional disrupted-in-schizophrenia 1 signaling featuring aberrant neurodevelopment and … JV Nani, MC Fonseca, SA Engi, MG Perillo, CSB Dias, ML Gazarini, ... Journal of Psychopharmacology 34 (4), 467-477, 2020 | 13 | 2020 |
| ACE activity in blood and brain axis in an animal model for schizophrenia: Effects of dopaminergic manipulation with antipsychotics and psychostimulants JV Nani, CM Yonamine, DC Musial, C Dal Mas, JJ Mari, MAF Hayashi The World Journal of Biological Psychiatry, 2019 | 13 | 2019 |
| Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders TC Santiago, L Parra, JV Nani, TM Fidalgo, NJ Bradshaw, MAF Hayashi Journal of Neurochemistry 166 (2), 138-155, 2023 | 11 | 2023 |
| Animal models in psychiatric disorder studies JV Nani, B Rodríguez, FC Cruz, MAF Hayashi, JV Nani, B Rodríguez, ... Animal models in medicine and biology, 57, 2019 | 10 | 2019 |
| Evaluation of NDEL1 oligopeptidase activity in blood and brain in an animal model of schizophrenia: effects of psychostimulants and antipsychotics JV Nani, RS Lee, CM Yonamine, OA Sant’Anna, MA Juliano, A Gadelha, ... Scientific reports 10 (1), 18513, 2020 | 8 | 2020 |
| A system biology approach based on metabolic biomarkers and protein–protein interactions for identifying pathways underlying schizophrenia and bipolar disorder M Altaf-Ul-Amin, K Hirose, JV Nani, LC Porta, L Tasic, SF Hossain, ... Scientific reports 11 (1), 14450, 2021 | 7 | 2021 |
| Impact of nuclear distribution element genes in the typical and atypical antipsychotics effects on nematode Caenorhabditis elegans: Putative animal model for studying the … GG Monte, JV Nani, MR de Almeida Campos, C Dal Mas, LAN Marins, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 92, 19-30, 2019 | 7 | 2019 |
| A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With … JV Nani, C Dal Mas, CM Yonamine, VK Ota, C Noto, SI Belangero, JJ Mari, ... International Journal of Neuropsychopharmacology 23 (11), 721-730, 2020 | 6 | 2020 |
| Neuropeptidases in psychiatric disorders JV Nani, PGC Almeida, M Hayashi Elsevier, 2021 | 4 | 2021 |
| Evaluation of tumor growth remission in a murine model for subcutaneous solid tumors–Benefits of associating the antitumor agent crotamine with mesoporous nanosilica particles … WY Oyadomari, GL Anthero, MRA Silva, LC Porta, V Oliveira, PF Reid, ... International Journal of Pharmaceutics 646, 123420, 2023 | 1 | 2023 |
| Identification of an ex vivo inhibitor of the schizophrenia biomarker Ndel1 by high throughput screening JV Nani, C Coelho, WY Oyadomari, TC Santiago, MM Machado, ... Biochemical Pharmacology 217, 115841, 2023 | 1 | 2023 |
| Assessing the role of Ndel1 oligopeptidase activity in congenital Zika syndrome: Potential predictor of congenital syndrome endophenotype and treatment response RR Christoff, JV Nani, G Lessa, T Rabello, AD Rossi, V Krenn, LM Higa, ... Journal of Neurochemistry 166 (4), 763-776, 2023 | 1 | 2023 |
| Unraveiling the correlation among neurodevelopmental and inflammatory biomarkers in patients with chronic schizophrenia JV Nani, PGC Almeida, C Noto, RA Bressan, E Brietzke, MAF Hayashi Nordic Journal of Psychiatry 76 (7), 559-564, 2022 | 1 | 2022 |
